If you are not sure if the website you would like to visit is secure, you can verify it here. Enter the website address of the page and see parts of its content and the thumbnail images on this site. None (if any) dangerous scripts on the referenced page will be executed. Additionally, if the selected site contains subpages, you can verify it (review) in batches containing 5 pages.

site address: firstwordpharma.com

site title: Pharma Industry News and Analysis - FirstWord Pharma

Our opinion:

GREEN status (no comments) - no comments
After content analysis of this website we propose the following hashtags:


Proceed to the page?Powered by: Very Tiny URL Shortener at http://vturl.net VeryTinyURL

Meta tags:
description=FirstWord Pharma - Your source for disease area news and pharma industry intelligence on biosimilars, market access, medical affairs, orphan drugs, pharma marketing, R&D, regulatory.;
keywords=pharma, pharmaceutical, pharmaceuticals, pharma news, pharmaceutical news, pharmaceutical industry news, pharma marketing news, pharmaceutical marketing news, pharma breaking news, biotech, biotech news, medical conferences, research, clinical trials, pharmaceutical companies, product news, FirstWord Dossier, pharma reports;

Headings (most frequently used words):

with, of, in, for, at, presented, news, therapeutics, the, to, views, announces, and, clinical, patients, results, asnc, wcn, market, disease, chronic, from, drugs, pfizer, rights, treatment, launches, springworks, four, startup, backed, 888711, european, medicines, agency, lusutrombopag, dccr, prader, willi, shionogi, syndrome, don, advice, join, hemophilia, trial, yingjie, jason, huang, ascentage, scientific, pharma, phase, senior, vice, president, development, soleno, receipt, as, elective, food, squibb, expand, collaboration, evaluating, ipi, 549, china, drug, bristol, administration, approves, gilead, sovaldi, sofosbuvir, hepatitis, virus, myers, pharmaceuticals, study, procedures, plus2, thrombocytopenia, liver, undergoing, cohort, invasive, simple, infinity, 15, minute, test, can, differentiate, mci, those, alzheimer, ongoing, predict, dosing, leading, toe, on, gene, therapy, pricing, debate, kol, pulmonologist, scripts, excited, about, new, severe, asthma, biologics, but, dips, express, competition, conference, miss, tags, today, insight, analysis, trending, my, latest, viewpoints, storywatch, physician, what, reception, awaits, glaxosmithkline, trelegy, ellipta, warns, will, subcutaneous, events, spect, heart, rate, response, may, cardiac, after, frame, kidney, transplant, catalyst, biosciences, successful, completion, first, czt, be, among, fierce, crowded, high, rates, diabetic, peripheral, neuropathy, youth, compared, diabetes, ecg, shows, superior, sensitivity, diagnosing, diastolic, dysfunction, infection,

Text of the page (most frequently used words):
tags (15), #views (14), #published (14), ago (13), the (12), and (12), #pharma (11), #affairs (11), ref (10), medicine (9), clinical (9), with (9), #market (9), for (8), news (8), #therapeutics (7), #physician (6), results (6), firstword (6), internal (6), access (6), research (6), medical (5), #press (5), new (5), fda (5), kol (5), conference (5), min (5), release (5), sales (5), asnc (5), marketing (5), regulatory (5), pricing (5), drugs (4), wcn (4), general (4), practice (4), dispatch (4), presented (4), novartis (4), payer (4), reimbursement (4), ellipta (4), viewpoints (4), four (4), all (4), springworks (4), pfizer (4), rights (4), leading (3), desk (3), bms (3), analysis (3), newswire (3), report (3), but (3), focus (3), corporate (3), about (3), strategies (3), gsk (3), from (3), announces (3), asthma (3), upgrade (3), express (3), gilead (3), hour (3), respiratory (3), hours (3), scripts (3), gene (3), pulmonary (3), companies (2), catalyst (2), will (2), biosciences (2), trending (2), amgen (2), showcase (2), advertise (2), reports (2), launches (2), trial (2), ascentage (2), astrazeneca (2), contact (2), tezepelumab (2), other (2), medicines (2), globenewswire (2), dccr (2), soleno (2), key (2), success (2), factors (2), johnson (2), partner (2), latest (2), financing (2), warns (2), biologics (2), severe (2), excited (2), pulmonologist (2), diagnostics (2), fierce (2), read (2), therapies (2), crowded (2), company (2), industry (2), monday (2), companion (2), more (2), therapy (2), your (2), use (2), diabetes (2), insight (2), poll (2), 2017 (2), days (2), competition (2), trelegy (2), startup (2), ipi (2), infectious (2), pharmaceuticals (2), infinity (2), storywatch (2), chronic (2), treatment (2), nirogacestat (2), 549 (2), product (2), sovaldi (2), can (2), patients (2), hepatitis (2), diseases (2), drug (2), disease (2), backed (2), colleague (2), shionogi (2), business (2), register (2), support, car, cell, kymriah, category, orphan, companywatch, luxturna, spark, conditionwatch, dips, winning, toe, productwatch, issues, home, debate, copd, therapeutic, breo, anoro, tech, what, reception, awaits, glaxosmithkline, medicalmeetingwatch, tracker, adcom, arthritis, teva, sanofi, regeneron, xolair, nucala, dupixent, lists, condition, september, biomarkers, plivensia, searches, benralizumab, spotlight, five, friday, meeting, regulatorywatch, notes, analyst, biomakers, alliances, rheumatoid, deals, saved, now, eisai, united, investigates, provide, podcasts, rss, twitter, contracts, innovative, mobile, insights, this, channel, commercialisation, their, renew, actionable, videos, how, executive, outcomes, progressive, don, delivering, miss, identifies, most, add, benchmarking, approach, appropriate, approvals, landscape, states, novel, yet, uptake, shaping, are, models, meets, today, where, abbott, allergan, astro, summary, merck, health, markets, changing, needs, earnings, free, ever, evolve, attitudes, policies, emerging, moved, being, keep, goalposts, biosimilars, rejects, spect, ticket, minute, interbrandhealth, alzheimer, those, mci, differentiate, test, 888711, simple, dementia, evaluating, collaboration, expand, squibb, lusutrombopag, phase, bristol, ema, prader, agency, european, advice, scientific, receipt, procedures, study, invasive, elective, undergoing, liver, thrombocytopenia, plus2, myers, opdivo, syndrome, terms, 0445784, senicapoc, licensing, refer, policy, top, privacy, reserved, limited, publishing, guide, doctor, copyright, 0325901, story, cancer, approves, breast, obstetrics, gynaecology, infection, virus, sofosbuvir, administration, financial, food, china, sciences, cfda, bloomberg, wire, forbes, times, willi, people, hot, diabetic, features, get, subscription, youth, among, neuropathy, peripheral, rates, launch, high, yesterday, contents, czt, frame, compared, announced, 103, diastolic, herceptin, costly, promising, needed, model, payment, says, biosimilar, million, open, oncologists, majority, include, experimental, well, dysfunction, diagnosing, development, successful, 2679d, abxis, isu, haemophilia, president, first, vice, senior, join, huang, jason, yingjie, completion, subcutaneous, sensitivity, cardiac, superior, shows, ecg, transplant, kidney, after, events, predict, dosing, may, response, rate, heart, hemophilia, ongoing, cohort, log,
Thumbnail images (randomly selected): * Images may be subject to copyright.GREEN status (no comments)

    No Images


    The site also has 2 references to external domain(s).

     fwreports.com  Verify  twitter.com  Verify


    Top 50 hastags from of all verified websites.

    Supplementary Information (add-on for SEO geeks)*- See more on header.verify-www.com

    Header

    HTTP/1.1 200 OK
    Date Mon, 25 Sep 2017 15:29:33 GMT
    X-Powered-By PHP/5.2.17
    Expires Sun, 19 Nov 1978 05:00:00 GMT
    Last-Modified Mon, 25 Sep 2017 15:29:33 GMT
    Cache-Control store, no-cache, must-revalidate
    Cache-Control post-check=0, pre-check=0
    Content-Type text/html; charset=utf-8
    Set-Cookie SESS03909d8dd07980d982d468fc48cba91e=vn5llns0aucdom8078doa6nt67; expires=Wed, 18-Oct-2017 19:02:53 GMT; path=/; domain=.firstwordpharma.com
    Set-Cookie anon_sid=vn5llns0aucdom8078doa6nt67; expires=Fri, 25-Sep-2037 11:44:52 GMT
    Connection close
    Transfer-Encoding chunked

    Meta Tags

    title="Pharma Industry News and Analysis - FirstWord Pharma"
    http-equiv="Content-Type" content="text/html; charset=utf-8"
    name="description" content="FirstWord Pharma - Your source for disease area news and pharma industry intelligence on biosimilars, market access, medical affairs, orphan drugs, pharma marketing, R&D, regulatory."
    name="keywords" content="pharma, pharmaceutical, pharmaceuticals, pharma news, pharmaceutical news, pharmaceutical industry news, pharma marketing news, pharmaceutical marketing news, pharma breaking news, biotech, biotech news, medical conferences, research, clinical trials, pharmaceutical companies, product news, FirstWord Dossier, pharma reports"
    http-equiv="Content-Type" content="text/html; charset=utf-8"

    Load Info

    page size70478
    load time (s)1.316405
    redirect count0
    speed download53538
    server IP84.207.240.203
    * all occurrences of the string "http://" have been changed to "htt???/"